Backlash: Post-Kavanaugh, Key Senate Races Have Turned

New Post Public Reply Private Reply Replies (1) Message Board
Lmcat Bhawks #50237
112
Backlash: Post-Kavanaugh, Key Senate Races Have Turned South for Democrats
Oct 10, 2018 2:01 PM

Even as Democrats remain the favorites to win back the House in less than a month, their prospects for capturing the Senate -- already a longshot, thanks to a very challenging map -- appear to be dimming even further.

Republican voters were re-engaged by the Kavanaugh battle, a phenomenon that could disproportionately benefit the party in red-leaning states hosting major Senate races this cycle.

Fortunately for the GOP, those are exactly the sorts of states that will decide the balance of power in the upper chamber. Whether this momentum can be sustained over the coming weeks is a crucial and open question, but for now, here's survey of the latest fallout:

ARIZONA - For the first time in weeks, a new poll shows Republican Martha McSally springing out to a lead over Democrat Kyrsten Sinema:

Kavanaugh effect? New Arizona Senate poll has McSally ahead of Sinema by 6. https://t.co/2awjtKHgFD
— Tom Bevan (@TomBevanRCP) October 10, 2018


The RealClearPolitics average in this race currently shows Sinema up by less than two points. It's unclear whether this new survey is an outlier or a trend; in evaluating that point, it's worth noting that this polling series from a local ABC affiliate showed McSally narrowly ahead, fleetingly, in early September (just after the primaries).

I'd like to see more data before declaring that McSally has truly made a comeback. That said, the GOP must be seeing something in the Arizona numbers, as they're deploying some heavy hitters to the state on McSally's behalf:

Bush and Romney to campaign for McSally's Senate bid in Arizona https://t.co/UTDHdgcKkO pic.twitter.com/hoFohKB65S
— The Hill (@thehill) October 10, 2018


Bush carried the state by ten points in 2004, and Romney by nine in 2012.

NORTH DAKOTA - In a cringe-worthy effort to explain her vote against Justice Kavanaugh, whose confirmation was overwhelmingly supported by her constituents, Sen. Heidi Heitkamp made a bizarre admission.
She says she determined that Kavanaugh was likely guilty of attempted sexual assault based on his body language during the impassioned testimony he delivered in his own defense. Before that, Heitkamp claims, she was leaning 'yes' on his nomination, but her mute-button pop psychology steered her in the opposite direction. Allahpundit is rightly appalled:

That’s a clown senator, bro...I don’t know how else to understand the clip below except as an admission that she’s resigned to losing. It’s one thing to vote against Kavanaugh when you represent a very red state, it’s another to admit on camera that you did it for the exceptionally goofy reason that you didn’t like his face when you watched him speak with the sound off. It’s a ready-made attack ad for Kevin Cramer.
Say this for much her, I guess: When you’ve got zippo by way of corroborating evidence of the claims against him, on what else can you base your opposition except something as gassy as body language?

This whole post is worth reading because it reminds everyone of the sort of stress Kavanaugh was under, and reviews the egregious demagoguery of Democrats on the Judiciary Committee, most of whom made no effort to even feign an attitude of basic fairness.

Fighting for his survival and reputation, and accused of facilitating serial gang rape, Kavanaugh's sound-off agitated demeanor rubbed Heidi the wrong way. What a joke. The derisive laughter gets louder when you realize that it's a transparent lie, too:

Wait, what? She told reporters anyone who decided their vote before viewing the FBI report did so “prematurely.” #NDSEN #NDpol https://t.co/14iAo4Q8Sk
— Jake Wilkins (@JakeWilkns) October 10, 2018


Her previous tale was that she remained undecided, pending the results of the FBI probe -- which produced zero new evidence against Kavanaugh, and actually raised new concerns about Team Ford's ethics and methods.
Anyone who reached their conclusion prior to carefully reviewing the FBI's work was jumping the gun, she intoned.
But now she spills that she'd made up her mind as a amateur body language interpreter days earlier.
Okay.
On average, Heitkamp is down by nearly nine percentage points on average, with the last two polls giving Republican Kevin Cramer a double-digit lead. But don't forget that she was viewed as cooked six years ago, yet pulled off a squeaker of an upset. The GOP shouldn't make that same mistake again.

MONTANA - With his race shifted to a pure "toss up" by the Cook Political Report, and the National Rifle Association downgrading his scorecard due to yet another vote against a pro-Second Amendment SCOTUS nominee, Sen. Jon Tester may not be feeling quite as confident about his re-election as he once was.
Reacting to Republican Matt Rosendale hyping the new NRA rating, Tester's Communications Director took to Twitter to "help:"

While you were busy making your millions developing Maryland farmland, @jontester was making a living shooting hundreds of cows and hogs. So I think Montanans know who gets guns. #mtpol #mtsen https://t.co/inVR3iW3Th
— Chris Meagher (@chrismeagher) October 9, 2018


Tester loves guns so much, he's spent the last decade rubber-stamping anti-Second Amendment judges and opposing pro-gun rights ones (including Justice Gorsuch). Oh, and he blows away...cows, or something. The NRA hilariously trolled back:

pic.twitter.com/gA6hIMvWwO
— NRA (@NRA) October 10, 2018


NEVADA - Republican Sen. Dean Heller is in the fight of his life, seeking re-election in a blue-ish state, in a blue year. But he pulled off a tight win in Obama-won Nevada six years ago, so don't count him out. Two new surveys show a very close race, with Heller slightly ahead. This is one of them:

NBC/Marist poll of NV-SEN (likely voters)
Heller (R) 46%
Rosen (D) 44%

Expanded ballot
Heller (R) 44%
Rosen (D) 42%
Hagan (L) 8%
None of these 2%

9/30-10/3, MOE +/- 5.5%
— Mark Murray (@mmurraypolitics) October 9, 2018


The good news for the GOP is that their Senate and gubernatorial nominees hold slight leads. The worrisome news is that the remaining undecideds have a low opinion of President Trump and lean Democratic. Late breakers could help Democrats overcome these moderate deficits.

TENNESSEE - Is Marsha Blackburn pulling away? The latest Fox poll has her up five points, the latest CBS poll shows her up eight, and the ongoing New York Times poll is, uh, not looking great for Democrat Phil Bredesen (nor Beto O'Rourke in Texas, for that matter):

Second Day Of Live Polling By @UpshotNYT/@SienaResearch:#TNsen:
Blackburn (R) 57 (+18)
Bredesen (D) 39
(366 LV)#TXsen:
Cruz (R - Inc) 53 (+9)
O’Rourke (D) 44
(526 LV)#NVsen:
Heller (R - inc) 46 (+1)
Rosen (D) 45
(464 LV)

*Numbers Are Still Not Final* https://t.co/laoHGQfVRB
— Political Polls (@PpollingNumbers) October 10, 2018

That's still a partial sample, but the gap has only grown since the survey went into the field a few days ago. Taylor Swift's advocacy may have gotten a few thousands voters registered in the Volunteer State, but the Kavanaugh controversy have clearly redounded to Blackburn's benefit at this point. Does Bredesen see the writing on the wall? For what it's worth, here's Blackburn responding directly to the pop star's criticisms on Fox Business Network.

https://townhall.com/tipsheet/guybenson/2018/...p=20589768
Scroll down for more posts ▼

Top 10 Most Recent News Articles

JNJ's Dual-Antigen Therapy Shows Promise in Prostate Cancer

Updated Category News Views 176

Exploring a New Front in Cancer Treatment Johnson & Johnson (NYSE: JNJ) just dropped a bombshell at the Society for Immunotherapy of Cancer (SITC) 2026 Annual Meeting, unveiling data that could reshape prostate cancer care. Their pioneering combo of pasritamig and JNJ-9401, a dual-antigen-targeted therapy, has the scientific community buzzing. Yeah, it's just Phase 1 baby...

Continue Reading
Novo's Semaglutide Shows Promise in MASH Study

Updated Category News Views 221

Semaglutide, a name on the lips of many investors looking for breakthroughs, is making waves again. This time, the stir comes from recent findings in the MASH field, and it's got folks in white coats quite excited. Revolutionary Results from Novo Novo Nordisk has announced promising results from their phase 3 ESSENCE trial that looks into semaglutide's effects on a...

Continue Reading
ASTS Faces Class Action; Investors Beware of Pitfalls

Updated Category News Views 183

Securities Fraud Allegations Hit AST SpaceMobile Days like this remind me why we keep our eyes peeled in the stock game—AST SpaceMobile (NASDAQ: ASTS) is tangled in a web of legal drama, and it's something you can't brush off with a shrug. Class action lawsuits for securities fraud? That's like finding out the foundation's shaky beneath a skyscraper. If you've got skin...

Continue Reading
Cleaner Air in Bedroom May Stabilize Blood Sugar Levels

Updated Category News Views 256

Imagine a world where simply sleeping in cleaner air could affect your blood sugar. Seems far-fetched, I know. But that's where we're at with this new study out of NYU Langone Health. They're talking about using plain ol' portable air filters to help steady blood sugar levels for folks dealing with prediabetes. Turns out a cleaner bedroom might just hold the key to taming...

Continue Reading
Gildan's Crisis: Investors Face Losses Amid Lawsuit

Updated Category News Views 150

Gildan Investors, Brace Yourself Poor old Gildan Activewear finds itself in hot water again, with a class action lawsuit cropping up like an unexpected storm on farmers' day. Any traders remotely involved with NYSE:GIL should pay damn close attention, because with a December 14, 2026 deadline looming, it's crunch time. The Root of the Lawsuit The plot thickens here,...

Continue Reading
Webull Faces Class Action Suit: Key Deadlines Loom

Updated Category News Views 140

The Clock is Ticking for Webull Investors If anyone's got a Webull stake, listen up! You’ve got a deadline that's staring you in the face: December 7, 2026. This is when you need to throw your hat in the ring to be a lead plaintiff in the Webull Corporation class action. We're talking securities fraud, folks, with allegations flying that would make your head spin....

Continue Reading
Quantum Space Joins $185M NASA Lunar Transport Deal

Updated Category News Views 863

Quantum Space Bags a Chunk of NASA's Lunar Ambitions Alright, folks, buckle up because we're about to dive into the cosmos. Quantum Space just nabbed a sweet deal—a $185 million whopper of a contract from NASA's Moon Base Transportation program. This isn't chump change; it's a 25% slice for Quantum from the lot Arrow Science and Technology is heading. We're talking...

Continue Reading
MWC26 Doha: Bridging Standards for MENA's Future

Updated Category News Views 437

MWC26 Doha Launches with a Connectivity Mission Forget corporate boardrooms; the real action this week is unfolding in Doha's bustling exhibition halls. Kicked off with the fanfare you'd expect from such a key event, MWC26 Doha has drawn a crowd that's got both tech geeks and policy wonks nodding with interest. This ain’t your average trade show: it’s the melting pot...

Continue Reading
Fibocom LTE Modules Test Drive Satellite Connectivity

Updated Category News Views 63

Boosting IoT with Satellite Connectivity Here's a good one for folks watching the edge of wireless innovation. Fibocom's LTE Cat.1 bis modules, the LE270-EU and LE271-GL, just stretched their legs in New Zealand, connecting seamlessly with SpaceX's Direct to Cell (DTC) satellite system. No fancy hardware swaps, just standard firmware strutting its stuff across satellite...

Continue Reading
TCL's Display Future: AI Meets Screens at DTC 2026

Updated Category News Views 578

Exploring New Horizons in Display Technology There's something brewing in Wuhan: a conference that’s shaping up like a tech enthusiast’s dream. This year, it's all about the symbiosis of cutting-edge tech and dazzling visuals as TCL CSOT gears up to unveil advancements at the Global Display Tech-Ecosystem Conference (DTC) 2026. If you're wondering whether this event...

Continue Reading

Top 5 Most Recently Viewed Articles

Market Response to Aluminium Tariff Threats and Implications

Updated Category News Views 121

Market Insights on Aluminium Pricing and Tariffs The aluminium market has been under scrutiny as recent events unfold regarding potential tariffs on Canadian imports. Despite rising aluminium prices for U.S. consumers since the presidential election, the increase has remained relatively moderate. This suggests that industry players are not overly concerned about the...

Continue Reading
Understanding the Booming Healthcare Asset Management Market

Updated Category News Views 230

Healthcare Asset Management Market Overview The Healthcare Asset Management market has been experiencing remarkable growth, with projections estimating its value to exceed USD 166.82 billion. This rapid expansion is driven by an impressive compound annual growth rate (CAGR) of 23.1% from 2024 to 2032. This article delves into the reasons behind this growth and what the...

Continue Reading
T1 Energy Inc. Faces Shareholder Investigation: What You Need to Know

Updated Category News Views 454

Understanding the Investigation of T1 Energy Inc. T1 Energy Inc. (NYSE: TE) is currently the focus of an important investigation launched by Purcell & Lefkowitz LLP, aimed at safeguarding the rights of its shareholders. This inquiry is centered on whether the directors have acted in accordance with their fiduciary duties regarding significant recent corporate actions. Why...

Continue Reading
Kimberly-Clark's Strategic Move to Shape Health and Wellness Market

Updated Category News Views 183

Kimberly-Clark's Transformative Acquisition In a remarkable move to bolster its position in the personal care products sector, Kimberly-Clark Corporation is poised to acquire Kenvue. This acquisition will create a formidable entity within the health and wellness market, valued at an impressive $32 billion. Kimberly-Clark, recognized for its commitment to sustainability...

Continue Reading
ADC Therapeutics Welcomes New Talent with Employee Grants

Updated Category News Views 106

ADC Therapeutics Expands Team with New Inducement Grant ADC Therapeutics SA (NYSE: ADCT), a leader in the field of antibody drug conjugates (ADCs), recently made headlines by offering a grant of options to acquire 6,000 of the company's common shares to a newly hired employee. This strategic move highlights the company's commitment to attracting top talent essential for...

Continue Reading